Junzhuo Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Junzhuo Wang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Fenglin Chen
Department of Gastroenterology and Fujian Institute of Digestive Disease, Fujian Medical University Union Hospital, Fuzhou, China
1 shared publication - Jianshun Chen
Changle Center for Disease Prevention and Control, Fuzhou, China
1 shared publication - Lingjun Yan
Department of Neurosurgery , Binhai Branch of National Regional Medical Center , The First Affiliated Hospital , Fujian Medical University , Fuzhou , Fujian , China , fjmu.edu.cn
1 shared publication - Wanxin Li
School of Public Health, Fujian Medical University, Fujian 350122, China
1 shared publication - Weimin Ye
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
1 shared publication - Ying Chen
Changle Institute for Cancer Research, Fuzhou, China
1 shared publication
Latest Publications
- 6 September 2023
- Published by Springer Nature in Phenomics
- Vol. 3 (5) , 496-501
Inflammation as a Mediator of Microbiome Dysbiosis-Associated DNA Methylation Changes in Gastric Premalignant Lesions
Evidence for the influence of chronic inflammation induced by microbial dysbiosis on aberrant DNA methylation supports a plausible connexion between disordered microbiota and precancerous lesions of gastric cancer (PLGC). Here, a comprehensive study including multi-omics data was performed to estimate the relationships amongst the gastric microbiome, inflammatory proteins and DNA methylation alterations and their roles in PLGC development. The results demonstrated that gastric dysbacteriosis increased the risk of PLGC and DNA methylation alterations in related tumour suppressor genes. Seven inflammatory biomarkers were identified for antrum and corpus tissues, respectively, amongst which the expression levels of several biomarkers were significantly correlated with the microbial dysbiosis index (MDI) and methylation status of specific tumour suppressor genes. Notably, mediation analysis revealed that microbial dysbiosis partially contributed to DNA methylation changes in the stomach via the inflammatory cytokines C–C motif chemokine 20 (CCL20) and tumour necrosis factor receptor superfamily member 9 (TNFRSF9). Overall, these results may provide new insights into the mechanisms that might link the gastric microbiome to PLGC.
- 6 September 2023
- Published by Springer Nature in Phenomics
- Vol. 3 (5) , 496-501
Inflammation as a Mediator of Microbiome Dysbiosis-Associated DNA Methylation Changes in Gastric Premalignant Lesions
Evidence for the influence of chronic inflammation induced by microbial dysbiosis on aberrant DNA methylation supports a plausible connexion between disordered microbiota and precancerous lesions of gastric cancer (PLGC). Here, a comprehensive study including multi-omics data was performed to estimate the relationships amongst the gastric microbiome, inflammatory proteins and DNA methylation alterations and their roles in PLGC development. The results demonstrated that gastric dysbacteriosis increased the risk of PLGC and DNA methylation alterations in related tumour suppressor genes. Seven inflammatory biomarkers were identified for antrum and corpus tissues, respectively, amongst which the expression levels of several biomarkers were significantly correlated with the microbial dysbiosis index (MDI) and methylation status of specific tumour suppressor genes. Notably, mediation analysis revealed that microbial dysbiosis partially contributed to DNA methylation changes in the stomach via the inflammatory cytokines C–C motif chemokine 20 (CCL20) and tumour necrosis factor receptor superfamily member 9 (TNFRSF9). Overall, these results may provide new insights into the mechanisms that might link the gastric microbiome to PLGC.